30 Dicembre 2008
Mandarin Fund compra Euticals
Mandarin Capital Partners ha acquisito l'84,5% del capitale della pmi milanese Euticals, con l'obiettivo di usare l'azienda chimico-farmaceutica come piattaforma per aggregare altre aziende specializzate nei principi attivi sia in Italia che all'estero, in particolare in Cina...[Fonte: Reuters]
|
30 Dicembre 2008
EC: Delay of Generic Drugs Costs Providers $3.8 Billion
EU healthcare providers could have saved an estimated $3.8 billion from 2000–2007 if the introduction of some generic medicines had not been delayed, the European Commission (EC) says in a preliminary report. The findings suggest that companies that make the first version of a drug adopt defensive patent strategies to block development of competing products.
|
30 Dicembre 2008
Teva Says Barr Pharma Buyout Is Complete
Teva Pharmaceutical Industries Ltd. said it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc., a rival maker of generic drugs and a major generic oral contraceptive company...[Fonte: CEP News]
|
<< precedente successiva >>